CNSP

CNS Pharmaceuticals, Inc. - Common Stock (CNSP)

About CNS Pharmaceuticals, Inc. - Common Stock (CNSP)

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Details

Daily high

$7.64

Daily low

$7.04

Price at open

$7.23

52 Week High

$114.00

52 Week Low

$4.93

Market cap

4.4M

Dividend yield

0.00%

Volume

6,885

Avg. volume

10,685

P/E ratio

-.12

CNS Pharmaceuticals, Inc. - Common Stock News